The anti‐inflammatory adipokine adiponectin has been speculated to play a role in COVID‐19 respiratory failure (Lockhart & O'Rahilly, 2020), but only one study has examined adiponectin levels in patients with COVID‐19 (Zelst et al., 2020). Here, ADIPOQ is linked to respiratory failure.